RESUMEN

Preeclampsia is a disorder specific of the human being that appears after 20 weeks of pregnancy, characterized by new onset of hypertension and proteinuria. Abnormal placentation and reduced placental perfusion associated to impaired trophoblast invasion and alteration in the compliance of uterine spiral arteries are the early pathological findings that are present before the clinical manifestations of preeclampsia. Later on, the endothelial and vascular dysfunction responsible of the characteristic vasoconstriction of preeclampsia appear. Different nutritional risk factors such as a maternal deficit in the intake of calcium, protein, vitamins and essential fatty acids, have been shown to play a role in the genesis of preeclampsia, but also an excess of weight gain during pregnancy or a pre-pregnancy state of obesity and overweight, which are associated to hyperinsulinism, insulin resistance and maternal systemic inflammation, are proposed as one of the mechanism that conduce to endothelial dysfunction, hypertension, proteinuria, thrombotic responses, multi-organ damage, and high maternal mortality and morbidity. Moreover, it has been demonstrated that pregnant women that suffer preeclampsia will have an increased risk of future cardiovascular disease and related mortality in their later life. In this article we will discuss the results of studies performed in different populations that have shown an interrelationship between obesity and overweight with the presence of preeclampsia. Moreover, we will review some of the common mechanisms that explain this interrelationship, particularly the alterations in the L-arginine/nitric oxide pathway as a crucial mechanism that is common to obesity, preeclampsia and cardiovascular diseases.

RESUMEN

BACKGROUND: The current study aims to evaluate the association between neck circumference (NC) and several cardio-metabolic risk factors, to compare it with well-established anthropometric indices, and to determine the cut-off point value of NC for predicting children at increased risk of metabolic syndrome, insulin resistance and low-grade systemic inflammation. METHODS: A total of 669 school children, aged 8-14, were recruited. Demographic, clinical, anthropometric and biochemical data from all patients were collected. Correlations between cardio-metabolic risk factors and NC and other anthropometric variables were evaluated using the Spearman's correlation coefficient. Multiple linear regression analysis was applied to further examine these associations. We then determined by receiver operating characteristic (ROC) analyses the optimal cut-off for NC for identifying children with elevated cardio-metabolic risk. RESULTS: NC was positively associated with fasting plasma glucose and triglycerides (p = 0.001 for all), and systolic and diastolic blood pressure, C-reactive protein, insulin and HOMA-IR (p < 0.001 for all), and negatively with HDL-C (p = 0.001). Whereas, other anthropometric indices were associated with fewer risk factors. CONCLUSIONS: NC could be used as clinically relevant and easy to implement indicator of cardio-metabolic risk in children.

Asunto(s)

Inflamación/diagnóstico , Síndrome Metabólico/diagnóstico , Cuello/anatomía & histología , Adolescente , Biomarcadores/sangre , Glucemia/metabolismo , Proteína C-Reactiva/metabolismo , Niño , Colombia , Estudios Transversales , Femenino , Humanos , Inflamación/sangre , Inflamación/etiología , Insulina/sangre , Resistencia a la Insulina , Modelos Lineales , Masculino , Síndrome Metabólico/sangre , Síndrome Metabólico/etiología , Curva ROC , Factores de Riesgo , Triglicéridos/sangre

RESUMEN

Hypertension affects 1 billion people worldwide and is considered the leading cause of death, stroke, myocardial infarction and congestive heart failure. Sodium intake is reported to be a modifiable determinant of hypertension and reductions in its consumption have been widely recommended. Various strategies have been proposed to address the observed epidemic of cardiovascular diseases, particularly in medium and low-income countries. Among these strategies, reducing dietary sodium intake and increasing dietary potassium intake are commonly included in guidelines for the treatment of hypertension and the prevention of cardiovascular disease. In the present article, we review the results of recent studies that have raised questions about potential adverse effects associated with low sodium intake on important health outcomes, including cardiovascular diseases and death. It is clear from these studies, that there are contradictory and irreconcilable positions in the interpretation of the evidence, a situation that indicates that there is an urgent need for international randomized controlled trials that consistently demonstrate that the low levels of sodium intake recommended in the guidelines are safe and beneficial for different populations around the world. In the interim, and in accordance with a number of experts, we agree that the current evidence argues against the reduction of dietary sodium as an isolated public health recommendation and that an alternative approach of recommending high quality, potassium rich diets, might achieve greater health benefits, including blood-pressure reduction, than aggressive sodium reduction alone.

Asunto(s)

Enfermedades Cardiovasculares/fisiopatología , Hipertensión/prevención & control , Potasio/administración & dosificación , Sodio en la Dieta/administración & dosificación , Enfermedades Cardiovasculares/prevención & control , Conductas Relacionadas con la Salud , Humanos , Hipertensión/epidemiología , Potasio/orina , Factores de Riesgo , Sodio/orina

RESUMEN

La hipertensión inducida por el embarazo, cuya forma proteinúrica es denominada preeclampsia (PE), es una alteración que ocurre en el segundo trimestre del embarazo, y se caracteriza por la presencia de hipertensión y proteinuria. Durante el embarazo normal ocurren cambios fisiológicos adaptativos que incluyen insulino-resistencia (IR), hiperlipidemia, hipercoagulabilidad, inflamación y un estado circulatorio hiperdinámico. Estos cambios se expresan de una forma exagerada en las mujeres que desarrollan PE, alteraciones que están presentes también en el clúster de factores de riesgo que conforman el denominado síndrome metabólico (SM), el cual es un factor de riesgo para el desarrollo de diabetes mellitus tipo 2 (DM2) y enfermedad cardiovascular (ECV). En la presente revisión proponemos que la disfunción endotelial es la alteración común que explica la presencia de estas dos enfermedades comunes en América Latina...

---

Pregnancy induced hypertension, called preeclampsia (PE) when accompanied by proteinuria, is an alteration that occurs in the second trimester of pregnancy and is characterized by presence of hypertension and proteinuria. Adaptative physiologic changes occur during normal pregnancy including insulin-resistance (IR), hyperlipidemia, hypercoagulability, inflammation, and hyperdynamic circulatory status. Expression of these changes is exaggerated in women developing PE. These alterations are also present in the metabolic syndrome (MS) risk factors cluster, which is in turn a risk factor for developing type 2 diabetes mellitus (DM2) and cardiovascular disease (CVD). In this review endothelial dysfunction is proposed as a common alteration that explains the presence of these two common diseases in Latin America...

Asunto(s)

Humanos , Aterosclerosis , Complicaciones del Embarazo , Endotelio Vascular , Hipertensión Inducida en el Embarazo , Preeclampsia , Síndrome Metabólico

RESUMEN

The recent Latin American and European guidelines published this year has proposed as a goal for blood pressure control in patients with diabetes type 2 a value similar or inferior to 140/90 mmHg. High blood pressure is the leading cause of cardiovascular diseases and deaths globally. Although once hypertension is detected, 80% of individuals are on a pharmacologic therapy only a minority is controlled. Diabetes also is a risk factor for other serious chronic diseases, including cardiovascular disease. Whether specifically targeting lower fasting glucose levels can reduce cardiovascular outcomes remains unknown. Hypertension is present in 20% to 60% of patients with type 2 diabetes, depending on age, ethnicity, obesity, and the presence of micro or macro albuminuria. High blood pressure substantially increases the risk of both macro and micro vascular complications, doubling the risk of all-cause mortality and stroke, tripling the risk of coronary heart disease and significantly hastening the progression of diabetic nephropathy, retinopathy, and neuropathy. Thus, blood pressure lowering is a major priority in preventing cardiovascular and renal events in patients with diabetes and hypertension. During many years the BP goals recommended in patients with diabetes were more aggressive than in patients without diabetes. As reviewed in this article many clinical trials have demonstrated not only the lack of benefits of lowering the BP below 130/80 mmHg, but also the J-shaped relationship in DM patients. Overall we discuss the importance of define the group of patients in whom significant BP reduction could be particularly dangerous and, on the other hand, those with a high risk of stroke who could benefit most from an intensive hypotensive therapy. In any case, the big challenge now is avoid the therapeutic inertia (leaving diabetic patients with BP values of 140/90 mmHg or higher) at all costs, as this would lead to an unacceptable toll in terms of human lives, suffering, and socioeconomic costs.